Azimuth Capital Management’s West Pharmaceutical WST Stock Holding History

Azimuth Capital Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	$10.5M	Sell	25,497 -22,101	-46%	-$9.08M	0.45%	76
2021 Q4	$22.3M	Sell	47,598 -1,016	-2%	-$477K	0.9%	26
2021 Q3	$20.6M	Sell	48,614 -309	-0.6%	-$131K	0.89%	26
2021 Q2	$17.6M	Buy	48,923 +972	+2%	+$349K	0.76%	39
2021 Q1	$13.5M	Buy	47,951 +545	+1%	+$154K	0.64%	56
2020 Q4	$13.4M	Buy	47,406 +443	+0.9%	+$126K	0.67%	45
2020 Q3	$12.9M	Sell	46,963 -34,462	-42%	-$9.47M	0.76%	47
2020 Q2	$18.5M	Sell	81,425 -23,420	-22%	-$5.32M	1.18%	11
2020 Q1	$16M	Buy	104,845 +339	+0.3%	+$51.6K	1.2%	13
2019 Q4	$15.7M	Buy	104,506 +200	+0.2%	+$30.1K	0.95%	30
2019 Q3	$14.8M	Buy	104,306 +54,352	+109%	+$7.71M	0.96%	29
2019 Q2	$6.25M	Sell	49,954 -1,482	-3%	-$185K	0.42%	86
2019 Q1	$5.67M	Sell	51,436 -4	-0%	-$441	0.38%	93
2018 Q4	$5.04M	Buy	51,440 +235	+0.5%	+$23K	0.39%	88
2018 Q3	$6.32M	Buy	51,205 +910	+2%	+$112K	0.42%	86
2018 Q2	$4.99M	Sell	50,295 -2,070	-4%	-$206K	0.36%	100
2018 Q1	$4.62M	Sell	52,365 -1,770	-3%	-$156K	0.34%	113
2017 Q4	$5.34M	Sell	54,135 -1,840	-3%	-$182K	0.39%	93
2017 Q3	$5.39M	Buy	55,975 +3,160	+6%	+$304K	0.4%	89
2017 Q2	$4.99M	Buy	52,815 +1,275	+2%	+$121K	0.39%	88
2017 Q1	$4.21M	Buy	51,540 +2,435	+5%	+$199K	0.34%	97
2016 Q4	$4.17M	Buy	49,105 +1,385	+3%	+$118K	0.36%	91
2016 Q3	$3.56M	Sell	47,720 -96,235	-67%	-$7.17M	0.31%	104
2016 Q2	$10.9M	Sell	143,955 -985	-0.7%	-$74.7K	0.98%	20
2016 Q1	$10M	Buy	144,940 +41,081	+40%	+$2.85M	0.96%	23
2015 Q4	$6.25M	Buy	103,859 +4,870	+5%	+$293K	0.61%	61
2015 Q3	$5.36M	Buy	98,989 +37,418	+61%	+$2.02M	0.56%	65
2015 Q2	$3.58M	Buy	61,571 +1,605	+3%	+$93.2K	0.35%	100
2015 Q1	$3.61M	Buy	59,966 +1,580	+3%	+$95.1K	0.35%	98
2014 Q4	$3.11M	Buy	58,386 +830	+1%	+$44.2K	0.32%	101
2014 Q3	$2.58M	Buy	57,556 +711	+1%	+$31.8K	0.28%	109
2014 Q2	$2.4M	Buy	+56,845	New	+$2.4M	0.27%	118